能量代谢的改善对代谢性高血压的影响  

Effect of improvement of energy metabolism on metabolic hypertension

作　　者：王学婷(综述) 詹晓蓉(审校)[1] WANG Xueting;ZHAN Xiaorong(Department of Endocrinology,First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)

机构地区：[1]哈尔滨医科大学附属第一医院内分泌科,哈尔滨150001

出　　处：《临床与病理杂志》2020年第5期1303-1306,共4页Journal of Clinical and Pathological Research

摘　　要：近20年来,随着人们生活方式的巨大变化,高血压病患病率在中国迅速增长,高血压的危险因素也发生了明显的变化。代谢异常成为我国高血压患病率升高的主要原因,是目前高血压的主要临床类型。关于代谢性高血压的治疗,单纯的降压药物治疗已不能控制血压,还需改善患者的代谢水平。In the past 20 years,with the great changes in people’s lifestyle,the prevalence rate of hypertension has increased rapidly in China,and the risk factors of hypertension have also changed significantly.Metabolic abnormality is the main reason for the high prevalence of hypertension in China,which is the main clinical type of hypertension at present.As for the treatment of metabolic hypertension,simple antihypertensive drug therapy often fails to control blood pressure and needs to improve the metabolic level of patients.

关 键 词：能量代谢 代谢性高血压 胰高血糖素样肽-1类似物 葡萄糖钠转运蛋白2抑制剂 二甲双胍 

分 类 号：R54[医药卫生—心血管疾病]